Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of autologous serum versus platelet-rich plasma eye drops for moderate to severe dry eye including Sjogren's syndrome
KCT0008103Phase 4Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of autologous serum artificial tears in dry eye syndrome (DED), Sjögren's syndrome, sponsored by Seoul St. Mary's Hospital. Started Mar 2018; status: completed.
02
Drugs
autologous serum artificial tears
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on KCT0008103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008103.